Each ml of solution for infusion contains 5 mg cetuximab.
Each vial of 20 ml contains 100 mg cetuximab.
Cetuximab is a chimeric monoclonal IgG1 antibody produced in a mammalian cell line (Sp2/0) by recombinant DNA technology.
Excipients/Inactive Ingredients: Sodium chloride, Glycine, Polysorbate 80, Citric acid monohydrate, Sodium hydroxide, Water for injections.